SURGICAL TREATMENT OF PATIENTS WITH EXTRAORGANIC TUMORS OF THE PELVIC LOCALIZATION WITH INVASION OF THE ILIAC VESSELS
The aim of our study was to determine the indications for expanding the scope of operations in patients with pelvic extraorgan local formations.
Materials and methods. The results of surgical treatment of 7 patients with nonorgan tumors of the pelvic localization, who underwent resection on the main vessels in connection with their involvement in the tumor process, are presented.
Results and discussion. A total of 7 interventions were performed on the iliac arteries — 2 resections with an end-to-end anastomosis and 5 prostheses (one case — the aorta resection with reconstruction with a bifurcation prosthesis).
Patients with pelvic extraorgan tumors are a special cohort of patients, due to the presence of several organs in a narrow space, which inevitably causes them to fit snugly to the tumor. Locally advanced tumor process in extraorganic tumors involving the main vessels of the pelvis and adjacent organs is not a reason to refuse surgery, and despite the complications, repeated recurrences and previous operations, are well tolerated by patients. This is especially important due to the lack of a real alternative to surgical treatment of this group of patients.
Conclusions. Surgical intervention in the treatment of pelvic inorganic tumors involving the main vessels is the only radical method of treatment. Invasion of the main arterial and venous vessels is not a contraindication to surgery in patients with pelvic tumors. Combined angioplastic interventions allow to achieve a long without recurrent period even after cytoreductive operations.
2. Rotte KH, Mateev B, Wirbatz W. Zur Diagnostik der primдren retroperitonealen Tumoren [Diagnosis of primary retroperitoneal tumors]. Dtsch Gesundheitsw. 1970 Dec 17;25(51):2397-405. German. PMID: 4925659.
3. Iacobuzio-Donahue CA, Michael C, Baez P, Kappagantula R, Hooper JE, Hollman TJ. Cancer biology as revealed by the research autopsy. Nat Rev Cancer. 2019;19(12):686-697. doi:10.1038/s41568-019-0199-4
4. Zhu P, Fan Z. Cancer stem cells and tumorigenesis. Biophys Rep. 2018;4(4):178-188. doi:10.1007/s41048-018-0062-2
5. Bulletin of the National Cancer Registry of Ukraine. Kyiv. 2021; Vol. 22
6. Mota MMDS, Bezerra ROF, Garcia MRT. Practical approach to primary retroperitoneal masses in adults. Radiol Bras. 2018;51(6):391-400. doi:10.1590/0100-3984.2017.0179
7. Fu F, Ma X, Lu Y, Xu H, Ma R. Clinicopathological Characteristics and Prognostic Prediction in Pseudomyxoma Peritonei Originating From Mucinous Ovarian Cancer. Front Oncol. 2021;11:641053. Published 2021 Apr 21. doi:10.3389/fonc.2021.641053
8. Mikuła-Pietrasik J, Uruski P, Tykarski A, Książek K. The peritoneal “soil” for a cancerous “seed”: a comprehensive review of the pathogenesis of intraperitoneal cancer metastases. Cell Mol Life Sci. 2018;75(3):509-525. doi:10.1007/ s00018-017-2663-1
9. Chew MH, Yeh YT, Toh EL, et al. Critical evaluation of contemporary management in a new Pelvic Exenteration Unit: The first 25 consecutive cases. World J Gastrointest Oncol. 2017;9(5):218-227. doi:10.4251/wjgo.v9.i5.218
10. Brown KG, Koh CE, Solomon MJ, Qasabian R, Robinson D, Dubenec S. Outcomes After En Bloc Iliac Vessel Excision and Reconstruction During Pelvic Exenteration. Dis Colon Rectum. 2015;58(9):850-856. doi:10.1097/ DCR.0000000000000421
11. Lau YC, Brown KGM, Lee P. Pelvic exenteration for locally advanced and recurrent rectal cancerhow much more? J Gastrointest Oncol. 2019;10(6):1207-1214. doi:10.21037/ jgo.2019.01.21
This work is licensed under a Creative Commons Attribution 4.0 International License.